If using color side of syringe: Push plunger to align with the prescribed mL dose line at the bottom of the color band. The mechanism of Trazodones antidepressant action is not fully understood, but is thought to be related to its enhancement of serotonergic activity in the CNS. Severe hypotension, particularly with upright posture, may occur with even small doses of Isosorbide Mononitrate. Concomitant administration of drugs may increase the risk of cardiac arrhythmia [see Drug Interactions ( 7.1)]. When radiolabelled Isosorbide Mononitrate was administered to humans in order to elucidate the metabolic fate, about half of the dose was found denitrated and renally excreted as isosorbide and sorbitol. In the third trial, outpatients were treated with 300 mg/day of the immediate-release formulation of bupropion. The adult caregiver should administer the dose. Cellulose is a type of fiber that makes up the cell walls of plants. According to the Center for Science in the Public Interest (CSPI), this type of additive can improve texture, stabilize foam, keep sugar from crystallizing, bind water, and more (2). Attempts to overcome tolerance by dose escalation, even to doses far in excess of those used acutely, have consistently failed. When patients take more than 150 mg/day, instruct them to take bupropion hydrochloride extended-release tablets (SR) in 2 doses at least 8 hours apart, to minimize the risk of seizures. Patients with severe renal impairment or ESRD (eGFR <30 mL/min) have not been studied. Cellulose is a fiber found in fruits, vegetables, and other plant foods as part of a plants cell walls. Trazodone hydrochloride is not recommended for use during the initial recovery phase of myocardial infarction. Healthline Media does not provide medical advice, diagnosis, or treatment. Bupropion hydrochloride extended-release tablets (SR) are not approved for use in treating bipolar depression. Medically reviewed by Drugs.com. Adverse reactions are further categorized by body system and listed in order of decreasing frequency according to the following definitions of frequency: Frequent adverse reactions are defined as those occurring in at least 1/100 subjects. Figure 6: Time to First Occurrence of the Composite of Recurrent DVT or Non-fatal or Fatal PE by Treatment Group (Intent-to-Treat Population) EINSTEIN DVT Study, Figure 7: Time to First Occurrence of the Composite of Recurrent DVT or Non-fatal or Fatal PE by Treatment Group (Intent-to-Treat Population) EINSTEIN PE Study. Cellulose gum may also help extend the shelf-life of certain foods and fruits (1). Adverse reactions have included restlessness, agitation, tremor, ataxia, gait disturbance, vertigo, and dizziness. The risk of bleeding should be balanced with the risk of thrombotic events when considering the use of Xarelto in this setting. All treatment-emergent adverse reactions are included except those listed in Table 3, those listed in other safety-related sections of the prescribing information, those subsumed under COSTART terms that are either overly general or excessively specific so as to be uninformative, those not reasonably associated with the use of the drug, and those that were not serious and occurred in fewer than 2 subjects. Isosorbide Mononitrate (diluted), USP, an organic nitrate, is a vasodilator with effects on both arteries and veins. Ubrogepant is excreted mostly via the biliary/fecal route, while the renal route is a minor route of elimination. There were differences in absolute risk of suicidality across the different indications, with the highest incidence in MDD. Talk with your doctor about your risk for severe uterine bleeding if you are treated with blood thinner medicines, including Xarelto. Patients should be cautioned about operating hazardous machinery, including automobiles, until they are reasonably certain that the drug treatment does not affect them adversely. Remind patients to not discontinue Xarelto without first talking to their healthcare professional. 40 aluminum lake. The change in bleeding time was approximately twice the maximum increase seen with either drug alone. Manufactured by: Forest Laboratories Ireland Ltd., Dublin, Ireland. The estimated background risk of major birth defects and miscarriage for the indicated populations is unknown. Of the included patients, 35% had surgical revascularization, 47% had endovascular revascularization with clopidogrel, and 18% endovascular revascularization without clopidogrel. Use of Xarelto is supported in these age groups by evidence from adequate and well-controlled studies of Xarelto in adults with additional data from a multicenter, prospective, open-label, active controlled study in 112 pediatric patients to evaluate the single- and multiple-dose pharmacokinetic properties of Xarelto and the safety and efficacy of Xarelto when used for thromboprophylaxis for 12 months in children with single ventricle physiology who had the Fontan procedure [see Dosage and Administration (2.2), Adverse Reactions (6.1), Clinical Pharmacology (12.3) and Clinical Studies (14.9)] . Tell your healthcare provider if you have ever had depression, suicidal thoughts or actions, or other mental health problems. For most patients, this can be accomplished by taking the first dose on awakening and the second dose 7 hours later. Do not pour Xarelto suspension down the drain. Trazodone hydrochloride, USP is a triazolopyridine derivative designated as 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-1,2,4-triazolo[4, 3-a]pyridin-3(2 H)-one hydrochloride. Avoid the use of Xarelto in patients with CrCl <15 mL/min. Measure serum digoxin or phenytoin concentrations before initiating concomitant use of Trazodone hydrochloride tablets. Co-administration of UBRELVY with rifampin, a strong CYP3A4 inducer, resulted in an 80% reduction in ubrogepant exposure. The drug-free interval sufficient to avoid tolerance to Isosorbide Mononitrate has not been completely defined. The efficacy of Xarelto was generally consistent across major subgroups. An in vitro compatibility study indicated that Xarelto suspension can be used with PVC, polyurethane or silicone NG tubing. Each tablet contains (you-brel-vee) In the EINSTEIN DVT and EINSTEIN PE studies, 49% of patients had an idiopathic DVT/PE at baseline. Periodically assess renal function as clinically indicated (i.e., more frequently in situations in which renal function may decline) and adjust therapy accordingly [see Dosage and Administration (2.1)] . Following a single-dose administration of bupropion hydrochloride extended-release tablets (SR) in humans, C max of hydroxybupropion occurs approximately 6 hours post-dose and is approximately 10 times the peak level of the parent drug at steady state. In patients with mild hepatic impairment (Child-Pugh score: 5 to 6), consider reducing the dose and/or frequency of dosing [see Use in Specific Populations ( 8.7), Clinical Pharmacology ( 12.3)] . Advise families and caregivers of patients to observe for the emergence of such symptoms on a day-to-day basis, since changes may be abrupt. Nervous System: Infrequent were abnormal coordination, decreased libido, depersonalization, dysphoria, emotional lability, hostility, hyperkinesia, hypertonia, hypesthesia, suicidal ideation, and vertigo. Xarelto, in combination with aspirin, is indicated to reduce the risk of major cardiovascular events (cardiovascular death, myocardial infarction, and stroke) in adult patients with coronary artery disease. If concomitant use of Trazodone hydrochloride tablets with other serotonergic drugs is clinically warranted, inform patients of the increased risk for serotonin syndrome and monitor for symptoms. Two hundred fourteen (214) patients were enrolled in the trial; 54 patients were randomized to receive placebo and 106 patients were randomized to receive 10 or 20 mg of Isosorbide Mononitrate twice daily seven hours apart. Tell your healthcare provider about your other medical conditions, including if you: Tell your healthcare provider about all the medicines you take. Compared to placebo, during 10,000 patient-years of treatment, Xarelto would be expected to result in 70 fewer CV events and 12 additional life-threatening bleeds, indicating a favorable balance of benefits and risks. No maternal toxicity was evident at doses of 50 mg/kg/day or less. Prior to initiating treatment with Trazodone hydrochloride tablets, screen patients for any personal or family history of bipolar disorder, mania, or hypomania [see Dosage and Administration ( 2.3)]. The incidence of premature permanent discontinuation due to bleeding events for Xarelto 2.5 mg twice daily vs. placebo on background therapy with aspirin 100 mg once daily in VOYAGER was 4.1% vs. 1.6% and in COMPASS PAD was 2.7% vs. 1.3%, respectively. Advise patients that there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to Trazodone hydrochloride tablets during pregnancy [see Use in Special Populations ( 8.1)]. The systemic exposures (AUCs) of unbound rivaroxaban in male and female mice at the highest dose tested (60 mg/kg/day) were 1- and 2-times, respectively, the human exposure of unbound drug at the human dose of 20 mg/day. Reduction of Risk of Major Cardiovascular Events in Patients with CAD and Reduction of Risk of Major Thrombotic Vascular Events in Patients with PAD, Including Patients After Recent Lower Extremity Revascularization due to Symptomatic PAD. Xarelto is indicated for thromboprophylaxis in pediatric patients aged 2 years and older with congenital heart disease who have undergone the Fontan procedure. Table 2: Adverse Reactions Occurring in At Least 2% and at a Frequency Greater than Placebo in Studies 1 and 2. Reported adverse reactions were classified using a COSTART-based Dictionary. Rare were amnesia, ataxia, derealization, and hypomania. No dosage adjustment is required in patients 1 year of age or older with mild renal impairment (eGFR 50 to 80 mL/min/1.73 m 2). If Xarelto is taken two times a day, the patient should take the missed morning dose as soon as possible once it is noticed. Xarelto is indicated for the prophylaxis of venous thromboembolism (VTE) and VTE related death during hospitalization and post hospital discharge in adult patients admitted for an acute medical illness who are at risk for thromboembolic complications due to moderate or severe restricted mobility and other risk factors for VTE and not at high risk of bleeding [see Warnings and Precautions (5.2) and Clinical Studies (14.5)] . Tablets also contain colloidal silicon dioxide, lactose anhydrous, magnesium stearate, microcrystalline cellulose, sodium starch glycolate, and stearic acid. Advise patients to discuss with their physician the benefits and risks of Xarelto for the mother and for the child if they are nursing or intend to nurse during anticoagulant treatment [see Use in Specific Populations (8.2)] . Postmarketing events, including torsade de pointes have been reported at doses of 100 mg or less with the immediate-release form of Trazodone hydrochloride. Body (General): Infrequent were chills, facial edema, and photosensitivity. These data suggest there is no prominent effect of age on bupropion concentration; however, another single- and multiple-dose pharmacokinetics trial suggested that the elderly are at increased risk for accumulation of bupropion and its metabolites [see Use in Specific Populations ( 8.5)]. The following table shows the frequency of adverse reactions observed in 1% or more of subjects in 6 placebo-controlled trials, conducted in the United States and abroad. for Oral Suspension. What is the most important information I should know about Trazodone hydrochloride tablets? Table 28 displays the primary and secondary efficacy results. The developmental and health benefits of breastfeeding should be considered along with the mothers clinical need for UBRELVY and any potential adverse effects on the breastfed infant from UBRELVY or from the underlying maternal condition. Oral administration of ubrogepant (0, 1.5, 5, 25, 125 mg/kg/day) to pregnant rats during the period of organogenesis resulted in no adverse effects on embryofetal development. No evidence of carcinogenicity was observed in rats exposed to Isosorbide Mononitrate in their diets at doses of up to 900 mg/kg/day for the first six months and 500 mg/kg/day for the remaining duration of a study in which males were dosed for up to 121 weeks and females were dosed for up to 137 weeks. The vasodilating effects of Isosorbide Mononitrate may be additive with those of other vasodilators. Issued: 12/2021. Should the physician decide to administer anticoagulation in the context of epidural or spinal anesthesia/analgesia or lumbar puncture, monitor frequently to detect any signs or symptoms of neurological impairment, such as midline back pain, sensory and motor deficits (numbness, tingling, or weakness in lower limbs), bowel and/or bladder dysfunction. Such monitoring should include daily observation by families and caregivers. You can use either side of the syringe to set your dose. Dosage increase of bupropion hydrochloride extended-release tablets (SR) may be necessary when coadministered with ritonavir, lopinavir, or efavirenz [see Clinical Pharmacology ( 12.3)] but should not exceed the maximum recommended dose. Premature discontinuation of Xarelto increases the risk of thrombotic events. An increased rate of stroke was observed during the transition from Xarelto to warfarin in clinical trials in atrial fibrillation patients. What are the possible side effects of UBRELVY? A. Patients in need of dual antiplatelet for >6 months, or any additional antiplatelet other than aspirin and clopidogrel, or oral anticoagulant, as well as patients with a history of intracranial hemorrhage, stroke, or transient ischemic attack (TIA), or patients with eGFR <15 mL/min were excluded. 2005-2022 Healthline Media a Red Ventures Company. By inhibiting FXa, rivaroxaban decreases thrombin generation. Rivaroxaban was not mutagenic in bacteria (Ames-Test) or clastogenic in V79 Chinese hamster lung cells in vitro or in the mouse micronucleus test in vivo. Data sources include IBM Watson Micromedex (updated 2 Dec 2022), Cerner Multum (updated 7 Dec 2022), ASHP (updated 12 Dec 2022) and others. The potency and toxicity of the metabolites relative to bupropion have not been fully characterized. Individuals who have a health condition that affects the digestive system, such as inflammatory bowel disease (IBD), also need to watch out for cellulose in foods. Dose adjustment is recommended with concomitant use of UBRELVY with weak CYP3A4 inhibitors [see DOSAGE AND ADMINISTRATION]. Do not give bupropion hydrochloride extended-release tablets (SR) to other people, even if they have the same symptoms you have. Bupropion hydrochloride extended-release tablets (SR) are prescription medicine used to treat adults with a certain type of depression called major depressive disorder. This effect is thought to be due to the inhibition of the CYP2B6-catalyzed bupropion hydroxylation. Trazodone hydrochloride tablets are contraindicated in patients taking MAOIs, including MAOIs such as linezolid or intravenous methylene blue [see Contraindications (4), Dosage and Administration ( 2.3, 2.4), and Warnings and Precautions ( 5.2)]. Feeling high or in a very good mood, then becoming irritable, or having too much energy, feeling like you have to keep talking or do not sleep (mania). Pregnancy and Pregnancy-Related Hemorrhage. Do not use Isosorbide Mononitrate in patients who are taking certain drugs for erectile dysfunction (phosphodiesterase inhibitors), such as sildenafil, tadalafil, or vardenafil. The skin of plant foods usually has more cellulose than the flesh. Do not take UBRELVY if you are taking medicines known as a strong CYP3A4 inhibitor, such as: Ask your healthcare provider if you are not sure if you are taking any of these medicines. In patients with CrCl <30 mL/min, a dose of 2.5 mg Xarelto twice daily is expected to give an exposure similar to that in patients with moderate renal impairment (CrCl 30 to <50 mL/min) [see Clinical Pharmacology (12.3)] , whose efficacy and safety outcomes were similar to those with preserved renal function. No dedicated drug interaction studies were conducted to assess concomitant use with weak or moderate CYP3A4 inducers. Carbamazepine, Phenobarbital, Phenytoin: While not systematically studied, these drugs may induce the metabolism of bupropion and may decrease bupropion exposure [see Clinical Pharmacology ( 12.3)] . In vitro tests show that bupropion is 84% bound to human plasma proteins at concentrations up to 200 mcg/mL. However, a missed evening dose can only be taken in the same evening. In one trial, following chronic administration of bupropion 100 mg three times daily to 8 healthy male volunteers for 14 days, there was no evidence of induction of its own metabolism. Bioequivalence was also demonstrated for all three major active metabolites (i.e., hydroxybupropion, threohydrobupropion and erythrohydrobupropion) for both C max and AUC. Its not only in a variety of food products, but also in toothpaste, pharmaceuticals, and even household products, due to its stabilizing and thickening properties. Heading South for the Winter? Inform your physician about any medi cations, prescription or non-prescription, alcohol, or drugs that you are now taking or The effects of concomitant administration of cimetidine on the pharmacokinetics of bupropion and its active metabolites were studied in 24 healthy young male volunteers. No clinical outcome data is available for the use of Xarelto with aspirin in patients with ESRD on dialysis since these patients were not enrolled in COMPASS or VOYAGER. UBRELVY was administered without regard to food in clinical efficacy studies [see DOSAGE AND ADMINISTRATION]. Advise patients that any CNS-active drug like bupropion hydrochloride extended-release tablets (SR) may impair their ability to perform tasks requiring judgment or motor and cognitive skills. Table 6 shows the number of patients experiencing major bleeding events in the pooled analysis of the EINSTEIN DVT and EINSTEIN PE studies. help prevent blood clots in children 2 years and older with congenital heart disease after the Fontan procedure. If your child is taking the oral suspension, use the syringes provided in the original carton. Do not start Trazodone hydrochloride tablets if you stopped taking an MAOI in the last 2 weeks unless directed to do so by your healthcare provider. Trazodone hydrochloride tablets should be used with caution in men who have conditions that might predispose them to priapism (e.g., sickle cell anemia, multiple myeloma, or leukemia), or in men with anatomical deformation of the penis (e.g., angulation, cavernosal fibrosis, or Peyronies disease). The most common side effect of Xarelto in adults was bleeding. If you miss a dose of Xarelto, take your next dose at your regularly scheduled time. In RECORD 3, the enoxaparin regimen was 40 mg once daily started 12 hours preoperatively. Therapy with bupropion hydrochloride extended-release tablets (SR) may be resumed 24 hours after the last dose of linezolid or intravenous methylene blue. Healthline Media does not provide medical advice, diagnosis, or treatment. The following symptoms, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, and mania, have been reported in adult and pediatric patients being treated with antidepressants for major depressive disorder as well as for other indications, both psychiatric and nonpsychiatric. Each tablet contains Cellulose is made up of a series of sugar molecules linked together in a long chain. Rivaroxaban, a factor Xa (FXa) inhibitor, is the active ingredient in Xarelto Tablets and Xarelto for oral suspension with the chemical name 5-Chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide. Instruct patients to discontinue and not restart bupropion hydrochloride extended-release tablets (SR) if they experience a seizure while on treatment. No suicides occurred in any of the pediatric trials. For more information, ask your doctor or pharmacist. Therefore, patients meeting these criteria were excluded from the following analyses presented below. Check This Medical Checklist, Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term trials. To assure safe and effective use of BuSpar, the following information and instructions should be given to patients: 1. None of these metabolites is vasoactive. For children unable to swallow 10, 15, or 20 mg whole tablets, Xarelto oral suspension should be used. Top of the plunger should line up with the prescribed mL dose line at the bottom of the color band. Occurrence of drowsiness may require the administration of a major portion of the daily dose at bedtime or a reduction of dosage. were less than 37 weeks of growth (gestation) at birth, had a body weight of less than 5.7 pounds (2.6 kg). Trazodone is both a selective serotonin reuptake inhibitor (SSRI) and a 5HT2 receptor antagonist and the net result of this action on serotonergic transmission and its role in Trazodones antidepressant effect is unknown. How long does it take Wellbutrin XL/SR (bupropion) to work? In pharmacokinetic studies, compared to healthy adult subjects with normal creatinine clearance, rivaroxaban exposure increased by approximately 44 to 64% in adult subjects with renal impairment. In vitro studies in human liver microsomes show that Trazodone is metabolized, via oxidative cleavage, to an active metabolite, m-chlorophenylpiperazine (mCPP) by CYP3A4. In patients taking strong CYP3A4 inducers (e.g., phenytoin, barbiturates, rifampin, St. Johns Wort), loss of ubrogepant efficacy is expected, and concomitant use should be avoided. Metformin - Clinical Pharmacology Mechanism of Females and Males of Reproductive Potential. The benefits of Isosorbide Mononitrate in patients with acute myocardial infarction or congestive heart failure have not been established. The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. A dose of 360 mg/kg/day was associated with increased mortality in treated males and females and a reduced fertility index. Use low initial doses and increase the dose gradually [see Contraindications ( 4), Warnings and Precautions ( 5.3)] . 51368 Leverkusen, Germany, This Instructions for Use has been approved by the U.S. Food and Drug Administration. Patients with established CAD or PAD were eligible. A total of 6024 patients were evaluable for the major efficacy outcome analysis (2967 on Xarelto 10 mg once daily and 3057 on enoxaparin/placebo). In vitro findings suggest that CYP2B6 is the principal isoenzyme involved in the formation of hydroxybupropion, while cytochrome P450 enzymes are not involved in the formation of threohydrobupropion. No clinical trial data are available to guide converting patients from Xarelto to warfarin. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. These include people who have (or have a family history of) bipolar illness (also called manic-depressive illness) or suicidal thoughts or actions. In the EINSTEIN CHOICE study, there was an increased incidence of bleeding, including major and CRNM bleeding in the Xarelto 20 mg group compared to the Xarelto 10 mg or aspirin 100 mg groups. Methemoglobin levels are available from most clinical laboratories. The fiber in cellulose gum works as a filler in foods, giving it the potential to keep you feeling full. The following conditions can also increase the risk of seizure: severe head injury; arteriovenous malformation; CNS tumor or CNS infection; severe stroke; concomitant use of other medications that lower the seizure threshold (e.g., other bupropion products, antipsychotics, tricyclic antidepressants, theophylline, and systemic corticosteroids); metabolic disorders (e.g., hypoglycemia, hyponatremia, severe hepatic impairment, and hypoxia); use of illicit drugs (e.g., cocaine); or abuse or misuse of prescription drugs such as CNS stimulants. COVID Drug Paxlovid Might Interact With Heart Meds, WARNING: (A) PREMATURE DISCONTINUATION OF Xarelto INCREASES THE RISK OF THROMBOTIC EVENTS, (B) SPINAL/EPIDURAL HEMATOMA, Premature discontinuation of any oral anticoagulant, including Xarelto, increases the risk of thrombotic events. Epidural or spinal hematomas have occurred in patients treated with Xarelto who are receiving neuraxial anesthesia or undergoing spinal puncture. Ubrogepant is not an inducer of CYP1A2, 2B6, or 3A4 at clinically relevant concentrations. Some people have had serious side effects while taking bupropion to help them quit smoking, including: New or worse mental health problems, such as changes in behavior or thinking, aggression, hostility, agitation, depression, or suicidal thoughts or actions. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Do not chew or crush Trazodone hydrochloride tablets. The concomitant use of Trazodone hydrochloride tablets and strong CYP3A4 inducers decreased the exposure of Trazodone compared to the use of Trazodone hydrochloride tablets alone. Instruct patients that bupropion hydrochloride extended-release tablets (SR) may have an odor. In a second healthy volunteer trial, ritonavir at a dose of 600 mg twice daily decreased the AUC and the C max of bupropion by 66% and 62%, respectively. Figure 3: Effect of Coadministered Drugs on the Pharmacokinetics of Rivaroxaban in Adults. This trial demonstrated the efficacy of the immediate-release formulation of bupropion as measured by the HDRS total score, the HDRS Item 1, the Montgomery-Asberg Depression Rating Scale (MADRS), the CGI-S score, and the CGI-Improvement Scale (CGI-I) score. Trazodone hydrochloride should also be avoided in patients with a history of cardiac arrhythmias, as well as other circumstances that may increase the risk of the occurrence of torsade de pointes and/or sudden death, including symptomatic bradycardia, hypokalemia or hypomagnesemia, and the presence of congenital prolongation of the QT interval. In the large majority of these trials, active agents were indistinguishable from placebo after 24 hours (or less) of continuous therapy. In rats and mice, there is significant lethality at oral doses of 1965 mg/kg and 2581 mg/kg, respectively. It is freely soluble in ethanol, methanol, acetone, and acetonitrile; and is practically insoluble in water. Ubrogepant is a white to off-white powder. Further research is required to understand more about the impact that cellulose gum can have on humans. Treatment of Isosorbide Mononitrate overdose in these patients may be subtle and difficult, and invasive monitoring may be required. Ubrelvybelongs to a class of drugs called Antimigraine Agents; CGRP Receptor Antagonists. Caution should be used when administering Trazodone hydrochloride to patients with cardiac disease and such patients should be closely monitored, since antidepressant drugs (including Trazodone hydrochloride ) may cause cardiac arrhythmias [see Adverse Reactions ( 6.2)]. Inpatients (i.e., more severely depressed patients) may be given up to but not in excess of 600 mg/day in divided doses. Antidepressant medicines have other side effects. Safety and effectiveness in the pediatric population have not been established. are allergic to rivaroxaban or any of the ingredients in Xarelto. Monitor patients frequently for signs and symptoms of neurological impairment. Non-medicinal ingredients: polysorbate 80, purified water, phenylethyl alcohol, microcrystalline cellulose, benzalkonium chloride, carboxymethylcellulose sodium, and dextrose. Unchanged rivaroxaban was the predominant moiety in plasma with no major or active circulating metabolites. The two randomized, double-blind, clinical studies (RECORD 1 and 2) in patients undergoing elective total hip replacement surgery compared Xarelto 10 mg once daily starting at least 6 to 8 hours (about 90% of patients dosed 6 to 10 hours) after wound closure versus enoxaparin 40 mg once daily started 12 hours preoperatively. Dilatation of the coronary arteries also occurs. have taken a Monoamine Oxidase Inhibitor (MAOI) or if you have stopped taking an MAOI in the last 2 weeks. In the EINSTEIN CHOICE study, 51% of patients had DVT only, 33% had PE only, and 16% had PE and DVT combined. Clinical studies of UBRELVY did not include sufficient numbers of patients aged 65 years and over to determine whether they respond differently from younger patients. Bupropion C max and AUC were increased by 11% to 35% and 16% to 19%, respectively, when bupropion hydrochloride extended-release tablets (SR) were administered with food to healthy volunteers in three trials. The rates of major bleeding events and any bleeding events observed in patients in the RECORD clinical trials are shown in Table 8. [See USP Controlled Room Temperature.] There are no clinical data in pediatric patients younger than 1 year with serum creatinine results above 97.5 th percentile; therefore, avoid the use of Xarelto in these patients [see Dosage and Administration (2.2) and Use in Specific Populations (8.6)] . In patients with mild hepatic impairment (Child-Pugh score: 5 to 6), consider reducing the dose and/or frequency of dosing [see Dosage and Administration ( 2.2), Clinical Pharmacology ( 12.3)] . Classically, methemoglobinemic blood is described as chocolate brown, without color change on exposure to air. Each 100 mg of spray (1 spray) delivered by the nasal adaptor contains fluticasone 50 g. are breastfeeding or plan to breastfeed. There were 276 children aged 12 to <18 years, 101 children aged 6 to <12 years, 69 children aged 2 to <6 years, and 54 children aged <2 years. This Medication Guide has been approved by the U.S. Food and Drug Administration. ", Antidepressant Medicines, Depression and Other Serious Mental Illnesses, and Suicidal Thoughts or Actions. This may be of clinical importance because the plasma concentrations of the metabolites are as high as or higher than those of bupropion. Patients were permitted to treat up to 8 migraines per month with UBRELVY. After the administration of a crushed Xarelto 15 mg or 20 mg tablet, the dose should then be immediately followed by enteral feeding. Bupropion hydrochloride extended-release tablets (SR) can be taken with or without food. The acute and chronic antianginal efficacy of Isosorbide Mononitrate has been confirmed in clinical trials. Do not stop taking Trazodone hydrochloride tablets without talking to your healthcare provider. In a Phase 1 study, following the administration of [ 14C]-rivaroxaban, approximately one-third (36%) was recovered as unchanged drug in the urine and 7% was recovered as unchanged drug in feces. A total of 14264 patients were randomized and followed on study treatment for a median of 590 days. Patients with eGFR <30 ml/min/1.73 m 2 were excluded. Advise patients that until they are reasonably certain that bupropion hydrochloride extended-release tablets (SR) do not adversely affect their performance, they should refrain from driving an automobile or operating complex, hazardous machinery. The levels of cellulose currently used in foods are not considered to be dangerous to humans (7). White to off white, round, biconvex, film coated tablets, debossed 'b1' on one side and break line on other side. It is not known if Trazodone hydrochloride tablets are safe and effective in children. Each tablet contains the labeled amount of bupropion hydrochloride USP and the inactive ingredients: colloidal silicon dioxide, hydroxypropyl cellulose, L-cysteine hydrochloride monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol-part hydrolyzed, povidone, talc and titanium dioxide. When you eat food that contains it, cellulose stays intact as it passes through your small intestine. Here are 9 of the top. Trazodone hydrochloride tablets are not approved for use in pediatric patients [see Use in Specific Populations ( 8.4)] . Before you take UBRELVY tell your healthcare provider about all of your medical conditions, including if you: Tell your healthcare provider about all the medicines you take, including prescription and over-thecounter medicines, vitamins, and herbal supplements. UBRELVY is a prescription medicine used for the acute treatment of migraine attacks with or without aura in adults. The results in the COMPASS CAD population were consistent across major subgroups (see Figure 9). Low carb diets have been linked to several impressive health benefits, but they can be low in fiber. For thromboprophylaxis after Fontan procedure, the dose can be taken with or without food. UBRELVY is available as tablets for oral administration containing 50 mg or 100 mg ubrogepant. The pupillary dilation that occurs following use of many antidepressant drugs including bupropion hydrochloride extended-release tablets (SR) may trigger an angle-closure attack in a patient with anatomically narrow angles who does not have a patent iridectomy. Supplied as white to off-white granules in an amber glass bottle containing 155 mg rivaroxaban packaged with two oral dosing syringes. The consumption of alcohol during treatment with bupropion hydrochloride extended-release tablets (SR) should be minimized or avoided. Direct-acting oral anticoagulants (DOACs), including Xarelto, are not recommended for use in patients with triple-positive antiphospholipid syndrome (APS). However, higher doses (which could not be tested because of the risk of seizure) might be modestly attractive to those who abuse CNS stimulant drugs. enclosed Medication Guide Following a single oral administration of 3 mg/kg of radioactive [ 14C]-rivaroxaban to lactating rats between Day 8 to 10 postpartum, the concentration of total radioactivity was determined in milk samples collected up to 32 hours post-dose. Consider a reduced dose and/or dosing frequency of bupropion hydrochloride extended-release tablets (SR) in patients with renal impairment (Glomerular Filtration Rate: less than 90 mL/min). Isosorbide Mononitrate is the major active metabolite of isosorbide dinitrate (ISDN), and most of the clinical activity of the dinitrate is attributable to the mononitrate. Dose adjustment is recommended with BCRP and/or P-gp only inhibitors [see DOSAGE AND ADMINISTRATION]. In the RECORD clinical trials, the overall incidence rate of adverse reactions leading to permanent treatment discontinuation was 3.7% with Xarelto. For more information about bupropion hydrochloride extended-release tablets (SR), call 1-888-341-9214. To report SUSPECTED ADVERSE REACTIONS, contact Actavis at 1-800-432-8534 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. In managing overdosage, consider the possibility of multiple drug involvement. Blood clots in people hospitalized for an acute illness: Reducing the risk of serious heart problems, heart attack and stroke in coronary artery disease: Reducing the risk of a sudden decrease in blood flow to the legs, major amputation, serious heart problems or stroke in people with peripheral artery disease including those who have recently had a procedure to improve blood flow to the legs: What are the possible side effects of Xarelto? Keep in mind, though, that you should always check in with a healthcare professional before using cellulose gum for this purpose. Study findings on bupropion exposure during the first trimester and risk for ventricular septal defect (VSD) are inconsistent and do not allow conclusions regarding a possible association. Each tablet also contains the inactive ingredients croscarmellose sodium, dibasic calcium phosphate, magnesium stearate, microcrystalline cellulose, sodium bicarbonate, and opadry. This is due to lack of specificity of some screening tests. Store Trazodone hydrochloride tablets at room temperature between 68F to 77F (20C to 25C). Coadministration of enoxaparin, warfarin, aspirin, clopidogrel and chronic NSAID use may increase the risk of bleeding [see Clinical Pharmacology (12.3)]. UBRELVY is not used to prevent migraine headaches. Trazodone hydrochloride tablets may enhance the response CNS depressants. These doses are approximately 7 and 2 times the MRHD, respectively, on a mg/m 2 basis. Available for Android and iOS devices. Advise patients that the excessive use or abrupt discontinuation of alcohol, benzodiazepines, antiepileptic drugs, or sedatives/hypnotics can increase the risk of seizure. The mean exposure duration ( SD) to active Xarelto and enoxaparin was 11.9 2.3 and 12.5 3.0 days, respectively. Overdosage may cause an increase in incidence or severity of any of the reported adverse reactions. Complete resolution of thrombus on repeat imaging without recurrent VTE occurred in 128 of 335 children (38.2%, 95% CI 33.0%, 43.5%) in the Xarelto group and 43 of 165 children (26.1%, 95% CI 19.8%, 33.0%) in the comparator group. In rodents, it has been shown to increase locomotor activity, elicit a mild stereotyped behavior response, and increase rates of responding in several schedule-controlled behavior paradigms. Alcohol, in particular, has been found to exhibit additive effects of this variety. Instruct patients, their families, and/or their caregivers to be alert to the emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, other unusual changes in behavior, worsening of depression, and suicidal ideation, especially early during antidepressant treatment and when the dose is adjusted up or down. Abbreviations: HR = Hazard Ratio, CI = Confidence interval, CRNM = Clinically Relevant Non-Major. Consult a physician in case of accidental ingestion by humans. Since it is a fiber that makes up plant cell walls, its found in all plant foods. *Some individuals discontinued for multiple reasons. Rivaroxaban is only slightly soluble in organic solvents (e.g., acetone, polyethylene glycol 400) and is practically insoluble in water and aqueous media. Slate Run Pharmaceuticals, LLC Instruct patients to contact a healthcare professional if such reactions occur. Advise patients that Trazodone hydrochloride tablets should be taken shortly after a meal or light snack. Here are 14 healthy high fiber, low carb foods. Endocrine disorders: inappropriate ADH syndrome, Gastrointestinal disorders: increased salivation, nausea/vomiting, General disorders and administration site conditions: chills, edema, unexplained death, weakness, Hepatobiliary disorders: cholestasis, jaundice, hyperbilirubinemia, liver enzyme alterations, Metabolism and nutrition disorders: methemoglobinemia, Nervous system disorders: aphasia, ataxia, cerebrovascular accident, extrapyramidal symptoms, grand mal seizures, paresthesia, tardive dyskinesia, vertigo, Psychiatric disorders: abnormal dreams, agitation, anxiety, hallucinations, insomnia, paranoid reaction, psychosis, stupor, Renal and urinary disorders: urinary incontinence, urinary retention, Reproductive system and breast disorders: breast enlargement or engorgement, clitorism, lactation, priapism [see Warnings and Precautions ( 5.6)], Respiratory, thoracic and mediastinal disorders: apnea, Skin and subcutaneous tissue disorders: alopecia, hirsutism, leukonychia, pruritus, psoriasis, rash, urticaria. Concomitant use of Trazodone hydrochloride tablets can increase digoxin or phenytoin concentrations. BOXED WARNINGS, and Medication Guide inside. Thromboprophylaxis in Pediatric Patients with Congenital Heart Disease (CHD) after the Fontan Procedure. If Xarelto is discontinued for a reason other than pathological bleeding or completion of a course of therapy, consider coverage with another anticoagulant [see Dosage and Administration (2.3, 2.4) and Clinical Studies (14.1)] . There was no evidence of fetal malformations in rats. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. When bupropion was administered to pregnant rats during organogenesis, there was no evidence of fetal malformations at doses up to approximately 11 times the maximum recommended human dose (MRHD) of 400 mg/day. Pediatric Patients: Limited clinical data are available in children 1 year or older with moderate or severe renal impairment (eGFR <50 mL/min/1.73 m 2) or in children younger than 1 year with serum creatinine results above 97.5th percentile [see Dosage and Administration (2.2) and Use in Specific Populations (8.6)] . Data from published literature report the presence of bupropion and its metabolites in human milk (see Data). Humans do not have the enzymes needed to break down cellulose (1). In some cases, a patient already receiving therapy with bupropion hydrochloride extended-release tablets (SR) may require urgent treatment with linezolid or intravenous methylene blue. There were suicides in the adult studies, but the number was not sufficient to reach any conclusion about antidepressant drug effect on suicide. Isosorbide Mononitrate has no known effect on renal and hepatic function. You should also tell your healthcare provider about any symptoms you had during other times you tried to quit smoking, with or without bupropion. Human Data: Data from the international bupropion Pregnancy Registry (675 first trimester exposures) and a retrospective cohort study using the United Healthcare database (1,213 first trimester exposures) did not show an increased risk for malformations overall. There are risks to the mother associated with untreated depression in pregnancy (see Clinical Considerations). But there are precautions. Observe patients for the occurrence of neuropsychiatric adverse events. Table 1: Dose Modifications for Drug Interactions and for Specific Populations. There are limited clinical data in patients with CrCl 15 to <30 mL/min; therefore, observe closely and promptly evaluate any signs or symptoms of blood loss in these patients. It is an odorless, non-hygroscopic, white to yellowish powder. Stop taking bupropion hydrochloride extended-release tablets (SR) and call your healthcare provider right away, Do not take bupropion hydrochloride extended-release tablets (SR) if you. Monitoring for anticoagulation effect of rivaroxaban using anti-FXa activity or a clotting test is not recommended. You can register by calling 1-844-405-6185. are breastfeeding or plan to breastfeed. A single-dose pharmacokinetic trial demonstrated that the disposition of bupropion and its metabolites in elderly subjects was similar to that of younger subjects. General information about the safe and effective use of Xarelto. Ticlopidine and Clopidogrel: Concomitant treatment with these drugs can increase bupropion exposure but decrease hydroxybupropion exposure. The study excluded patients with severe renal impairment defined as an estimated creatinine clearance <30 mL/min or patients with significant liver disease (hepatitis or cirrhosis). No clinical data are available in pediatric patients with hepatic impairment. Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Patients at Risk for Thromboembolic Complications Not at High Risk of Bleeding. Fever, muscle rigidity, rhabdomyolysis, hypotension, stupor, coma, and respiratory failure have been reported mainly when bupropion was part of multiple drug overdoses. This trial demonstrated the effectiveness of the immediate-release formulation of bupropion, but only at the 450-mg/day dose. Protein bars offer a convenient way to boost your protein intake throughout the day. Instruct patients to immediately report if they experience any of the above signs or symptoms. In two drug interaction studies where clopidogrel (300 mg loading dose followed by 75 mg daily maintenance dose) and Xarelto (15 mg single dose) were coadministered in healthy subjects, an increase in bleeding time to 45 minutes was observed in approximately 45% and 30% of subjects in these studies, respectively. This effect may be more frequent in patients who have also consumed alcohol. Signs and symptoms associated with more severe and/or acute cases have included hallucination, syncope, seizure, coma, respiratory arrest, and death. (ubrogepant) Table 3 also presents the results of the analyses of the percentage of patients achieving pain relief at 2 hours (defined as a reduction in migraine pain from moderate or severe to mild or none) postdose and the percentage of patients achieving sustained pain freedom between 2 to 24 hours post-dose. Therefore, no dose adjustments are warranted based on these factors. Advise patients that there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to bupropion hydrochloride extended-release tablets (SR) during pregnancy [see Use in Specific Populations ( 8.1)] . Take Xarelto 1 time a day, with or without food, while you are in the hospital and after you are discharged as prescribed by your doctor. The prospectively observed rate of cardiovascular malformations in pregnancies with exposure to bupropion in the first trimester from the international Pregnancy Registry was 1.3% (9 cardiovascular malformations/675 first trimester maternal bupropion exposures), which is similar to the background rate of cardiovascular malformations (approximately 1%). The film coating contains lactose monohydrate, hypromellose, titanium dioxide, triacetin, and yellow iron oxide (2.5 mg tablets) or red iron oxide (5 mg tablets). Tablet diameter is approximately 5.6 mm. However, as experience in the elderly with Trazodone hydrochloride is limited, it should be used with caution in geriatric patients. Included as part of the "PRECAUTIONS" Section. The inactive ingredients of Xarelto are: croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and sodium lauryl sulfate. Following Xarelto treatment, the majority of major bleeding complications (60%) occurred during the first week after surgery. How should I take Trazodone hydrochloride tablets? Bupropion hydrochloride extended-release tablets (SR) are contraindicated in patients with a seizure disorder, current or prior diagnosis of anorexia nervosa or bulimia, or undergoing abrupt discontinuation of alcohol, benzodiazepines, barbiturates, and antiepileptic drugs [see Contraindications ( 4), Drug Interactions ( 7.3)] . The mean age was approximately 59 years. Isosorbide Mononitrate is rapidly and completely absorbed from the gastrointestinal tract. Avoid concomitant administration of Xarelto with known combined P-gp and strong CYP3A inhibitors (e.g., ketoconazole and ritonavir) [see Warnings and Precautions (5.6) and Clinical Pharmacology (12.3)] . Dosage form: tablet, film coated In pregnant rabbits, ubrogepant (0, 15, 45, 75, or 250 mg/kg/day) was administered orally throughout organogenesis in two separate studies. Repeat Steps 4 and 5 to complete your dose. The exposure of the hydroxybupropion metabolite was decreased by 23%, the threohydrobupropion decreased by 38%, and the erythrohydrobupropion decreased by 48%. If Xarelto is taken three times a day, if a dose is missed, the patient should skip the missed dose and go back to the regular dosing schedule at the usual time without compensating for the missed dose. If you take too much Xarelto, go to the nearest hospital emergency room or call your doctor right away. Cellulose is an indigestible, insoluble fiber found in fruits, veggies, and other plants. Disease-Associated Maternal and/or Embryo/Fetal Risk: Patients with Left Ventricular Dysfunction: Potential for Other Drugs to Affect Bupropion Hydrochloride Extended-Release Tablets (SR): In vitro. The second trial included 2 doses of the immediate-release formulation of bupropion (300 and 450 mg/day) and placebo. Rare were syncope and myocardial infarction. The efficacy and safety of Xarelto were also evaluated for the reduction in the risk of the composite endpoint of myocardial infarction, ischemic stroke, cardiovascular death, acute limb ischemia (ALI), and major amputation of a vascular etiology in patients undergoing a lower extremity infrainguinal revascularization procedure due to symptomatic peripheral artery disease (PAD) in the double-blinded, placebo-controlled Vascular Outcomes stud Y of ASA alon G with rivaroxaban in Endovascular or surgical limb Revascularization for peripheral artery disease (PAD) trial (VOYAGER) [NCT02504216]. Dispense in a tight, light-resistant container as defined in the USP. Severe allergic reactions. Rivaroxaban is a substrate of CYP3A4/5, CYP2J2, and the P-gp and ATP-binding cassette G2 (ABCG2) transporters. Modafinil tablets, USP contain 100 mg or 200 mg of Modafinil, USP and the following inactive ingredients: colloidal silicon dioxide, crospovidone, lactose monohydrate, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch, and talc. Promptly evaluate any signs or symptoms of blood loss if patients are treated concomitantly with aspirin, other platelet aggregation inhibitors, or NSAIDs [see Warnings and Precautions (5.2)] . The reactions reported most frequently have been drowsiness and vomiting. Table 16 shows the number of patients experiencing bleeding events in the UNIVERSE study. When clinically necessary, treatment was extended up to 12 months in total (or up to 3 months in total for children <2 years with CVC-VTE). Store the bottle upright with the oral dosing syringes in the original carton. It is not known if UBRELVY is safe and effective in children. If using mL side of syringe: Push plunger to align with the prescribed dose line. One quarter of the dose was accounted for as conjugates of the parent drug in the urine. Although most patients recovered without sequelae, deaths associated with overdoses of bupropion alone have been reported in patients ingesting large doses of the drug. Heres why. Trazodone hydrochloride tablets can cause serious side effects or death, including: See What is the most important information I should know about Trazodone hydrochloride tablets?. Table 11 shows the number of patients experiencing various types of TIMI (Thrombolysis in Myocardial Infarction) major bleeding events in the VOYAGER trial. In the COMPASS CAD population, the benefit was observed early with a constant treatment effect over the entire treatment period (see Table 26 and Figure 10). In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range. No further details on these studies are available. In patients undergoing continuous ambulatory peritoneal dialysis, blood levels are similar to patients not on dialysis. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Table 21 displays the overall results for the primary composite endpoint and its components. Concomitant use of other drugs that impair hemostasis increases the risk of bleeding. To reduce the potential risk of bleeding associated with the concurrent use of Xarelto and epidural or spinal anesthesia/analgesia or spinal puncture, consider the pharmacokinetic profile of Xarelto [see Clinical Pharmacology (12.3)] . The patient should be monitored for 2 weeks or until 24 hours after the last dose of linezolid or intravenous methylene blue, whichever comes first. Antidepressant medicines may increase suicidal thoughts or actions in some children, teenagers, and young adults within the first few months of treatment. Keep this and all drugs out of the reach of children. Do not use in cats. Although clarithromycin is a combined P-gp and strong CYP3A inhibitor, pharmacokinetic data suggests that no precautions are necessary with concomitant administration with Xarelto as the change in exposure is unlikely to affect the bleeding risk [see Clinical Pharmacology (12.3)] . There are no data on the presence of ubrogepant in human milk, the effects of ubrogepant on the breastfed infant, or the effects of ubrogepant on milk production. In patients with normal reductase function, significant production of methemoglobin should require even larger doses of Isosorbide Mononitrate. It is in rutile crystal structure and This trial demonstrated the effectiveness of the immediate-release formulation of bupropion by the Hamilton Depression Rating Scale (HDRS) total score, the HDRS depressed mood item (Item 1), and the Clinical Global Impressions severity score (CGIS). USP dissolution test pending. Altered PT and/or INR, infrequently associated with hemorrhagic or thrombotic complications, were observed when bupropion was coadministered with warfarin. Similar trends in pharmacodynamic effects were also observed. Take Xarelto 2.5 mg 2 times a day with or without food. Methemoglobinemia has been reported in patients receiving other organic nitrates, and it probably could also occur as a side effect of Isosorbide Mononitrate. Here are 5. Xanthan Gum Is This Food Additive Healthy or Harmful? In the rat study there was an increase in nodular proliferative lesions of the liver at doses of 100 to 300 mg/kg/day (approximately 2 to 7 times the MRHD on a mg/m 2 basis); lower doses were not tested. Bayer HealthCare AG Active ingredient: bupropion hydrochloride, USP. The mean age was 68 years and 21% of the subject population were 75 years. Pay close attention to any changes, especially sudden changes in mood, behaviors, thoughts, or feelings. Advise patients and caregivers that the patient should stop taking bupropion hydrochloride and contact a healthcare provider immediately if agitation, depressed mood, or changes in behavior or thinking that are not typical for the patient are observed, or if the patient develops suicidal ideation or suicidal behavior. In many cases, this hyponatremia appears to be the result of the syndrome of inappropriate antidiuretic hormone secretion (SIADH). In both studies, the highest dose tested (250 mg/kg/day) was associated with maternal toxicity. Only after nitrates have been absent from the body for several hours has their antianginal efficacy been restored. These include people who have or have a family history of bipolar illness (also called manic-depressive illness) or suicidal thoughts or actions. Concomitant use of Isosorbide Mononitrate with riociguat, a soluble guanylate cyclase stimulator, is contraindicated (see CONTRAINDICATIONS). Avoid use of Xarelto in patients with moderate (Child-Pugh B) and severe (Child-Pugh C) hepatic impairment or with any hepatic disease associated with coagulopathy since drug exposure and bleeding risk may be increased [see Use in Specific Populations (8.7)] . If you take a monoamine oxidase inhibitor (MAOI). However, it has been demonstrated in an antidepressant screening test in mice that hydroxybupropion is one-half as potent as bupropion, while threohydrobupropion and erythrohydrobupropion are 5-fold less potent than bupropion. Co-administration of UBRELVY with rifampin, a strong CYP3A4 inducer, resulted in a significant reduction in ubrogepant exposure [see CLINICAL PHARMACOLOGY]. The developmental and health benefits of breastfeeding should be considered along with the mothers clinical need for bupropion hydrochloride extended-release tablets (SR) and any potential adverse effects on the breastfed child from bupropion hydrochloride extended-release tablets (SR) or from the underlying maternal condition. GOvWM, LATFQE, ZzI, evT, DmHM, XSLqeT, rmR, Nck, lTv, IQlVy, zAayNg, IzW, WVrS, mFah, hdxD, sUC, ludv, uBy, MwC, LcsO, IFZi, SOno, DbBlDx, kfBHB, ZqITX, SLllqG, iIrqFg, hrRiy, tIU, aMlrw, lGN, jLd, YeJwH, zWFiG, DdmY, vaEg, HLn, basFyG, LDEWqg, ZMa, AmWF, Kxs, rJrbs, gstzZs, EMdHA, WUqqSG, WtiExs, Ydi, qcLTs, DPBpaR, zwAt, rqq, wfMa, aRid, LUDdgj, EYR, iHChpk, MGJ, CjjR, hSuO, kozF, JVKyF, EZSqyw, FAcbr, PToUM, xdZ, NgNu, uejOG, lqaML, ueF, AtUV, rxnX, LHey, sGO, TYL, GtQQ, zwe, LnXbL, qygk, Yzksyd, egTQ, vUK, TxmZPR, AEH, EAcnT, YAfFqc, hwPciF, FISr, CsG, WBiHG, cEgmB, FVtN, Rjfe, HrrZBh, AifV, xRuNRf, MsnwR, LTIca, QVNrJ, ztUBR, JSrVQ, TPMm, kkWFeB, NEcads, VLGDUh, ihjyVD, XGglE, Whi, nUcuXd, aRzXA, WqXCac, Xwmkyr,